{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T12:03:38Z","timestamp":1766318618135,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIBERER U-703","PI17\/00021","PI17\/00109, PI17\/00021, PI\/00166 and PI15\/01082"],"award-info":[{"award-number":["CIBERER U-703","PI17\/00021","PI17\/00109, PI17\/00021, PI\/00166 and PI15\/01082"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universidad del Gobierno de Arag&amp;#x00F3;n"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Identifying diseases displaying chronic low plasma Coenzyme Q<jats:sub>10<\/jats:sub> (CoQ) values may be important to prevent possible cardiovascular dysfunction. The aim of this study was to retrospectively evaluate plasma CoQ concentrations in a large cohort of pediatric and young adult patients. We evaluated plasma CoQ values in 597 individuals (age range 1 month to 43 years, average 11 years), studied during the period 2005\u20132016. Patients were classified into 6 different groups: control group of healthy participants, phenylketonuric patients (PKU), patients with mucopolysaccharidoses (MPS), patients with other inborn errors of metabolism (IEM), patients with neurogenetic diseases, and individuals with neurological diseases with no genetic diagnosis. Plasma total CoQ was measured by reverse-phase high-performance liquid chromatography with electrochemical detection and ultraviolet detection at 275\u2009nm. ANOVA with Bonferroni correction showed that plasma CoQ values were significantly lower in the PKU and MPS groups than in controls and neurological patients. The IEM group showed intermediate values that were not significantly different from those of the controls. In PKU patients, the Chi-Square test showed a significant association between having low plasma CoQ values and being classic PKU patients. The percentage of neurogenetic and other neurological patients with low CoQ values was low (below 8%). In conclusi\u00f3n, plasma CoQ monitoring in selected groups of patients with different IEM (especially in PKU and MPS patients, but also in IEM under protein-restricted diets) seems advisable to prevent the possibility of a chronic blood CoQ suboptimal status in such groups of patients.<\/jats:p>","DOI":"10.1038\/s41598-018-37542-2","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T11:02:48Z","timestamp":1548673368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Plasma coenzyme Q10 status is impaired in selected genetic conditions"],"prefix":"10.1038","volume":"9","author":[{"given":"Raquel","family":"Montero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia","family":"Yubero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Julieta","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Campistol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria del Mar","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merc\u00e8","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Delgadillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Maynou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guerau","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Ruiz-Pesini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Meavilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viruna","family":"Neergheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angels","family":"Garc\u00eda-Cazorla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Placido","family":"Navas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain","family":"Hargreaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-9685","authenticated-orcid":false,"given":"Rafael","family":"Artuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"issue":"Suppl","key":"37542_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.mito.2007.02.011","volume":"7","author":"FL Crane","year":"2007","unstructured":"Crane, F. L. Discovery of ubiquinone (coenzyme Q) and an overview of function. Mitochondrion 7(Suppl), S2\u20137 (2007).","journal-title":"Mitochondrion"},{"key":"37542_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0925-4439(95)00028-3","volume":"1271","author":"L Ernster","year":"1995","unstructured":"Ernster, L. & Dallner, G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1271, 195\u2013204 (1995).","journal-title":"Biochim. Biophys. Acta"},{"issue":"Suppl","key":"37542_CR3","doi-asserted-by":"publisher","first-page":"S251","DOI":"10.1016\/S0098-2997(97)00003-4","volume":"18","author":"C Weber","year":"1997","unstructured":"Weber, C., Bysted, A. & Holmer, G. Coenzyme Q10 in the diet\u2013daily intake and relative bioavailability. Mol. Aspects Med. 18(Suppl), S251\u2013254 (1997).","journal-title":"Mol. Aspects Med."},{"key":"37542_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-1033.1987.tb13379.x","volume":"168","author":"PG Elmberger","year":"1987","unstructured":"Elmberger, P. G., Kalen, A., Appelkvist., E. L. & Dallner, G. In vitro and in vivo synthesis of dolichol and other main mevalonate products in various organs of the rat. Eur. J. Biochem. 168, 1\u201311 (1987).","journal-title":"Eur. J. Biochem."},{"key":"37542_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0005-2760(92)90237-P","volume":"1126","author":"D Mohr","year":"1992","unstructured":"Mohr, D., Bowry, V. W. & Stocker, R. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochim. Biophys. Acta 1126, 247\u2013254 (1992).","journal-title":"Biochim. Biophys. Acta"},{"key":"37542_CR6","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1073\/pnas.88.5.1646","volume":"88","author":"R Stocker","year":"1991","unstructured":"Stocker, R., Bowry, V. W. & Frei, B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation tan does alpha-tocopherol. Proc. Natl. Acad. Sci. USA 88, 1646\u20131650 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"37542_CR7","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.ijcard.2012.04.156","volume":"167","author":"U Alehagen","year":"2013","unstructured":"Alehagen, U., Johansson, P., Bj\u00f6rnstedt, M., Ros\u00e9n, A. & Dahlstr\u00f6m, U. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. Int. J. Cardiol. 167, 1860\u20131866 (2013).","journal-title":"Int. J. Cardiol."},{"key":"37542_CR8","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/j.jchf.2014.06.008","volume":"2","author":"SA Mortensen","year":"2014","unstructured":"Mortensen, S. A. et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail 2, 2641\u20132649 (2014).","journal-title":"JACC Heart Fail"},{"issue":"Suppl","key":"37542_CR9","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.mito.2007.03.007","volume":"7","author":"UC Tran","year":"2007","unstructured":"Tran, U. C. & Clarke, C. F. Endogenous synthesis of coenzyme Q in eukaryotes. Mitochondrion 7(Suppl), S62\u201371 (2007).","journal-title":"Mitochondrion"},{"key":"37542_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1258\/000456303321610493","volume":"40","author":"IP Hargreaves","year":"2003","unstructured":"Hargreaves, I. P. Ubiquinone: cholesterol\u2019s reclusive cousin. Ann. Clin. Biochem. 40, 207\u2013218 (2003).","journal-title":"Ann. Clin. Biochem."},{"key":"37542_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/00041433-200108000-00007","volume":"12","author":"R Mashima","year":"2001","unstructured":"Mashima, R., Witting, P. K. & Stocker, R. Oxidants and antioxidants in atherosclerosis. Curr. Opin. Lipidol. 12, 411\u2013418 (2001).","journal-title":"Curr. Opin. Lipidol."},{"key":"37542_CR12","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/ajcn\/70.5.892","volume":"70","author":"R Artuch","year":"1999","unstructured":"Artuch, R. et al. Decreased serum ubiquinone-10 concentrations in phenylketonuria. Am. J. Clin. Nutr. 70, 892\u2013895 (1999).","journal-title":"Am. J. Clin. Nutr."},{"key":"37542_CR13","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1056\/NEJM198606193142504","volume":"314","author":"G Hoffmann","year":"1986","unstructured":"Hoffmann, G. et al. Mevalonic aciduria: an inborn error of colesterol and nonsterol isoprene biosynthesis. N. Engl. J. Med. 314, 1610\u20131614 (1986).","journal-title":"N. Engl. J. Med."},{"key":"37542_CR14","unstructured":"Neergheen, V. & Hargreaves, I. P. Uses, health effects and role in disease. (ed. Grigoryeva, S.) 89\u2013111 (Nova Science, 2018)."},{"key":"37542_CR15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10545-011-9342-4","volume":"34","author":"V Delgadillo","year":"2011","unstructured":"Delgadillo, V., O\u2019Callaghan, M. M., Artuch, R., Montero, R. & Pineda, M. Genistein supplementation in patients affected by Sanfilippo disease. J. Inherit. Metab. Dis. 34, 1039\u20131044 (2011).","journal-title":"J. Inherit. Metab. Dis."},{"key":"37542_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/biof.5520320123","volume":"32","author":"D Haas","year":"2008","unstructured":"Haas, D., Niklowitz, P., Hoffmann, G. F., Andler, W. & Menke, T. Plasma and thrombocyte levels of coenzyme Q10 in children with Smith-Lemli-Opitz syndrome (SLOS) and the influence of HMG-CoA reductase inhibitors. Biofactors 32, 191\u2013197 (2008).","journal-title":"Biofactors"},{"key":"37542_CR17","first-page":"153","volume":"61","author":"T Menke","year":"2004","unstructured":"Menke, T., Niklowitz, P., Reinehr, T., de Sousa, G. J. & Andler, W. Plasma levels of coenzyme Q10 in children with hyperthyroidism. Horm. Res. 61, 153\u2013158 (2004).","journal-title":"Horm. Res."},{"key":"37542_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1097\/01.mpg.0000233193.77521.66","volume":"43","author":"JH Oudshoorn","year":"2006","unstructured":"Oudshoorn, J. H. et al. Decreased coenzyme Q10 concentration in plasma of children with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 43, 646\u2013650 (2006).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"37542_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1086\/301920","volume":"63","author":"P Guldberg","year":"1998","unstructured":"Guldberg, P. et al. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am. J. Hum. Genet. 63, 71\u201379 (1998).","journal-title":"Am. J. Hum. Genet."},{"key":"37542_CR20","unstructured":"PAHvdb: Phenylalanine Hydroxylase Gene Locus-Specific Database, http:\/\/www.Biopku.org (2018)."},{"key":"37542_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0009-9120(01)00249-1","volume":"34","author":"C Colome","year":"2001","unstructured":"Colome, C. et al. Is there a relationship between plasma phenylalanine and cholesterol in phenylketonuric patients under dietary treatment? Clin. Biochem. 34, 373\u2013376 (2001).","journal-title":"Clin. Biochem."},{"key":"37542_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.clinbiochem.2008.03.007","volume":"41","author":"R Montero","year":"2008","unstructured":"Montero, R. et al. Analysis of coenzyme Q10 in muscle and fibroblasts for the diagnosis of CoQ10 deficiency syndromes. Clin. Biochem. 41, 697\u2013700 (2008).","journal-title":"Clin. Biochem."},{"key":"37542_CR23","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1373\/clinchem.2005.054643","volume":"51","author":"AJ Duncan","year":"2005","unstructured":"Duncan, A. J. et al. Determination of coenzyme Q10 status in blood mononuclear cells, skeletal muscle and plasma by HPLC with a di-propoxy-coenzyme Q10 as an internal standard. Clin. Chem. 51, 2380\u20132382 (2005).","journal-title":"Clin. Chem."},{"key":"37542_CR24","doi-asserted-by":"publisher","first-page":"e0156359","DOI":"10.1371\/journal.pone.0156359","volume":"11","author":"D Yubero","year":"2016","unstructured":"Yubero, D. et al. Targeted Next Generation Sequencing in Patients with Inborn Errors of Metabolism. PLoS One 11, e0156359, https:\/\/doi.org\/10.1371\/journal.pone.0156359 (2016).","journal-title":"PLoS One"},{"key":"37542_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u201324 (2015).","journal-title":"Genet. Med."},{"key":"37542_CR26","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1093\/clinchem\/44.11.2378","volume":"44","author":"R Artuch","year":"1998","unstructured":"Artuch, R., Moreno, J., Quintana, M., Puig, R. M. & Vilaseca, M. A. Serum ubiquinone-10 in a pediatric population. Clin. Chem. 44, 2378\u20132379 (1998).","journal-title":"Clin. Chem."},{"key":"37542_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/biof.5520200306","volume":"20","author":"T Menke","year":"2004","unstructured":"Menke, T. et al. Plasma levels and redox status of coenzyme Q10 in infants and children. Biofactors 20, 173\u2013181 (2004).","journal-title":"Biofactors"},{"key":"37542_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0009-8981(03)00137-2","volume":"332","author":"MV Miles","year":"2003","unstructured":"Miles, M. V. et al. Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults. Clin. Chim. Acta. 332, 123\u201332 (2003).","journal-title":"Clin. Chim. Acta."},{"key":"37542_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1373\/clinchem.2004.043653","volume":"51","author":"SL Molyneux","year":"2005","unstructured":"Molyneux, S. L., Florkowski, C. M., Lever, M. & George, P. M. Biological Variation of Coenzyme Q10. Clin. Chem. 51, 455\u2013457 (2005).","journal-title":"Clin. Chem."},{"key":"37542_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1023\/A:1010500502275","volume":"24","author":"R Artuch","year":"2001","unstructured":"Artuch, R. et al. Plasma phenylalanine is associated with decreased ubiquinone-10 concentrations in phenyketonuria. J. Inherit. Metab. Dis. 24, 359\u2013366 (2001).","journal-title":"J. Inherit. Metab. Dis."},{"key":"37542_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/BF00973296","volume":"13","author":"M Castillo","year":"1988","unstructured":"Castillo, M., Zafra, M. F. & Garcia-Peregrin, E. Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate 5-pyrophosphate decarboxylase in experimental hyperphenylalainemia. Neurochem. Res. 13, 551\u2013555 (1988).","journal-title":"Neurochem. Res."},{"key":"37542_CR32","first-page":"1","volume":"25","author":"D Yubero","year":"2016","unstructured":"Yubero, D. et al. Coenzyme Q10 and Pyridoxal Phosphate Deficiency Is a Common Feature in Mucopolysaccharidosis Type III. JIMD. Rep. 25, 1\u20137 (2016).","journal-title":"JIMD. Rep."},{"key":"37542_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/biof.5520090236","volume":"9","author":"R Willis","year":"1999","unstructured":"Willis, R., Antony, M., Sun, L., Honse, Y. & Qiao, G. Clinical implications of the correlation between coenzyme Q10 and vitamin B6 status. Biofactors 9, 359\u2013363 (1999).","journal-title":"Biofactors"},{"key":"37542_CR34","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/brain\/awm054","volume":"130","author":"K Gempel","year":"2007","unstructured":"Gempel, K. et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 130, 2037\u20132044 (2007).","journal-title":"Brain"},{"key":"37542_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.mito.2014.07.001","volume":"17","author":"J Baruteau","year":"2014","unstructured":"Baruteau, J. et al. Successful reversal of propionic acidaemia associated cardiomyopathy: evidence for low myocardial coenzyme Q10 status and secondary mitochondrial dysfunction as an underlying pathophysiological mechanism. Mitochondrion 17, 150\u2013156 (2014).","journal-title":"Mitochondrion"},{"key":"37542_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mito.2016.06.007","volume":"30","author":"D Yubero","year":"2016","unstructured":"Yubero, D. et al. Secondary coenzyme Q10 deficiencies in oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders. Mitochondrion 30, 51\u201358 (2016).","journal-title":"Mitochondrion"},{"key":"37542_CR37","first-page":"2881","volume":"25","author":"F Degenhardt","year":"2016","unstructured":"Degenhardt, F. et al. Genome-wide association study of serum coenzyme Q10 levels identifies susceptibility loci linked to neuronal diseases. Hum. Mol. Genet. 25, 2881\u20132891 (2016).","journal-title":"Hum. Mol. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37542-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37542-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37542-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:14:17Z","timestamp":1671254057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37542-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37542"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37542-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"26 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"793"}}